TABLE 1. GLOBAL CANCER VACCINES MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 2. GLOBAL DENDRITIC CELLS CANCER VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL RECOMBINANT CANCER VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL ANTIGEN/ADJUVANT CANCER VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL WHOLE CELL CANCER VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL VIRAL VECTOR AND DNA CANCER VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL CANCER VACCINES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 8. GLOBAL PREVENTIVE CANCER VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL THERAPEUTIC CANCER VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL CANCER VACCINES MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL CANCER VACCINES MARKET FOR CERVICAL CANCER, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL CANCER VACCINES MARKET FOR PROSTATE CANCER, BY REGION, 2016-2023 ($MILLION)
TABLE 13. GLOBAL CANCER VACCINES MARKET FOR OTHER INDICATIONS BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL CANCER VACCINES MARKET, BY END USE, 2016-2023 ($MILLION)
TABLE 15. GLOBAL CANCER VACCINES MARKET FOR PEDIATRICS, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL CANCER VACCINES MARKET FOR ADULTS, BY REGION, 2016-2023 ($MILLION)
TABLE 17. GLOBAL CANCER VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA CANCER VACCINES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA CANCER VACCINES MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA CANCER VACCINES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA CANCER VACCINES MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 22. NORTH AMERICA CANCER VACCINES MARKET, BY END USE, 2016-2023 ($MILLION)
TABLE 23. EUROPE CANCER VACCINES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 24. EUROPE CANCER VACCINES MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 25. EUROPE CANCER VACCINES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 26. EUROPE CANCER VACCINES MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 27. EUROPE CANCER VACCINES MARKET, BY END USE, 2016-2023 ($MILLION)
TABLE 28. ASIA-PACIFIC CANCER VACCINES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 29. ASIA-PACIFIC CANCER VACCINES MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC CANCER VACCINES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC CANCER VACCINES MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 32. ASIA-PACIFIC CANCER VACCINES MARKET, BY END USE, 2016-2023 ($MILLION)
TABLE 33. LAMEA CANCER VACCINES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 34. LAMEA CANCER VACCINES MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 35. LAMEA CANCER VACCINES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 36. LAMEA CANCER VACCINES MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 37. LAMEA CANCER VACCINES MARKET, BY END USE, 2016-2023 ($MILLION)
TABLE 38. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 39. ASTRAZENECA: OPERATING SEGMENTS
TABLE 40. GSK: COMPANY SNAPSHOT
TABLE 41. GSK: OPERATING SEGMENTS
TABLE 42. MERCK: COMPANY SNAPSHOT
TABLE 43. MERCK: OPERATING SEGMENTS
TABLE 44. SANOFI: COMPANY SNAPSHOT
TABLE 45. SANOFI: OPERATING SEGMENTS
TABLE 46. ADURO: COMPANY SNAPSHOT
TABLE 47. ADURO: OPERATING SEGMENTS
TABLE 48. SANPOWER: COMPANY SNAPSHOT
TABLE 49. SANPOWER: OPERATING SEGMENTS
TABLE 50. ASTELLAS: COMPANY SNAPSHOT
TABLE 51. ASTELLAS: OPERATING SEGMENTS
TABLE 52. CSL: COMPANY SNAPSHOT
TABLE 53. CSL: OPERATING SEGMENTS
TABLE 54. PFIZER: COMPANY SNAPSHOT
TABLE 55. PFIZER: OPERATING SEGMENTS
TABLE 56. SERUM: COMPANY SNAPSHOT
TABLE 57. SERUM: OPERATING SEGMENTS

LIST OF FIGURE

FIGURE 1. GLOBAL CANCER VACCINES MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF CANCER VACCINES MARKET
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL CANCER VACCINES MARKET
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL CANCER VACCINES MARKET
FIGURE 13. U.S. CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 15. CANADA CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 16. UK CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 17. FRANCE CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 18. GERMANY CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 19. ITALY CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 20. SPAIN CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 21. REST OF EUROPE CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 22. JAPAN CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 23. CHINA CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 24. INDIA CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 25. AUSTRALIA CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 27. BRAZIL CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 28. ARGENTINA CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 29. TURKEY CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 30. SOUTH AFRICA CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 31. REST OF LAMEA CANCER VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 32. ASTRAZENECA: NET SALES, 2014-2016 ($MILLION)
FIGURE 33. ASTRAZENECA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 34. ASTRAZENECA: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 35. GSK: NET SALES, 2014-2016 ($MILLION)
FIGURE 36. GSK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 37. GSK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 38. MERCK: NET SALES, 2014-2016 ($MILLION)
FIGURE 39. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 40. MERCK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 41. SANOFI: NET SALES, 2014-2016 ($MILLION)
FIGURE 42. SANOFI: REVENUE BY SEGMENT, 2016 (%)
FIGURE 43. SANOFI: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 44. ADURO: NET SALES, 2014-2016 ($MILLION)
FIGURE 45. ADURO: REVENUE BY SEGMENT, 2016 (%)
FIGURE 46. ADURO: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 47. SANPOWER: NET SALES, 2014-2016 ($MILLION)
FIGURE 48. SANPOWER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 49. SANPOWER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 50. ASTELLAS: NET SALES, 2014-2016 ($MILLION)
FIGURE 51. ASTELLAS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 52. ASTELLAS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 53. CSL: NET SALES, 2014-2016 ($MILLION)
FIGURE 54. CSL: REVENUE BY SEGMENT, 2016 (%)
FIGURE 55. CSL: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 56. PFIZER: NET SALES, 2014-2016 ($MILLION)
FIGURE 57. PFIZER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 58. PFIZER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 59. SERUM: NET SALES, 2014-2016 ($MILLION)
FIGURE 60. SERUM: REVENUE BY SEGMENT, 2016 (%)
FIGURE 61. SERUM: REVENUE BY GEOGRAPHY, 2016 (%)